AbbVie Hit with $150M Verdict in “Low-T” Trial
The first jury verdict in a series of bellwether trials involving the testosterone treatment AndroGel is in. The jury found that the manufacturer of the gel, AbbVie, should pay $150 million in punitive damages to Oregon resident Jesse Mitchell. After seeing a commercial about AndroGel…